Suzhou Highfine Biotech Co., Ltd.
昊帆生物
301393
Shenzhen Stock Exchange
Company Profile
1、Strong Technical Service & Rapid Response Founded in 2003, Highfine is one of the early high-tech enterprises in China specializing in the R&D, production, and sales of peptide synthesis reagents. After nearly two decades of development, it has accumulated extensive R&D achievements in the field of organic synthesis. It has established a complete and independent core technology system in R&D and production of products such as peptide synthesis reagents, general-purpose molecular building blocks, and protein reagents. These strong technical capabilities not only enhance product quality and market competitiveness but also enable the R&D team to quickly develop customized synthesis processes for special customer needs, providing diverse tailored services that drive the company’s sustainable growth. With most main products in stock, the company ensures rapid response to customer demands, a critical advantage in the time-sensitive pharmaceutical industry. 2、Diverse Product Portfolio & High Added Value As an upstream service provider in the bio-pharmaceutical industry, the company leverages the brand advantage of its comprehensive, high-performance peptide synthesis reagents to rapidly introduce molecular building blocks and protein reagents with broader market demand and higher technical barriers. It also actively expands into emerging fields such as liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids, PROTAC reagents, and nucleotide reagents. This rich product matrix serves as the core vehicle for technology industrialization, fully meeting the procurement needs of downstream customers in the bio-pharmaceutical sector. 3、Extensive Customer Base & Strong Loyalty Highfine serves over 1,900 domestic and foreign pharmaceutical R&D and manufacturing enterprises, as well as CROs and CDMOs, including multinational giants like Bachem AG and Lonza, and leading Chinese outsourcing firms such as WuXi AppTec, Asymchem, and PharmaBlock. These customers have strict supplier certification processes, and once a trusting partnership is established, it tends to be stable and deepening over time. 4、Talented Team & Strong Brand As one of China’s early movers in peptide synthesis reagent R&D/production and protein reagent development, the company has built a professional, stable R&D team with over 20 years of experience in technology industrialization, capable of delivering customized solutions and professional services. Core technical staff possess deep expertise in peptide synthesis reagent R&D and production. With over two decades of focus on peptide synthesis reagents, the company has gained recognition at home and abroad. Its industry strength and influence make it a preferred partner for downstream customers seeking peptide synthesis reagents.
Full description
Highfine Biotech focuses on the R&D, production, and sales of peptide synthesis reagents. Its products cover the full range of synthesis reagents used in the synthesis of amide bonds during the R&D and production of downstream small molecule chemical drugs and peptide drugs. At the same time, based on customer needs and differentiated competitive strategies, and relying on its dominant position in the peptide synthesis reagent industry, the company has developed general-purpose building blocks and protein reagent products with strong technical barriers and good market prospects. It has formed a product system with peptide synthesis reagents as the mainstay and general-purpose building blocks and protein reagents as supplements. In addition, the company keeps up with the global drug research and development trends, closely follows the market demands of domestic and foreign CRO and CDMO companies, and actively makes arrangements in the fields of high-value-added and high-barrier characteristic products such as liposome pharmaceutical reagents, ionic liquids, PROTAC reagents, and nucleotide reagents, which have higher synthesis technical thresholds. It continuously expands its product pipeline and is committed to providing characteristic functional chemicals for global pharmaceutical research and development and production enterprises, as well as CRO and CDMO companies, precisely and efficiently contributing to the development of the global pharmaceutical industry.